Jana Grieb über Chancen und Risiken einer zunehmenden Regulierung durch MDR (Medical Devices Regulation) und REACH (Registration, Evaluation, Authorization, and Restriction.
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.
